Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

S-Venlafaxine (CAS 93413-44-6)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
1-[(1S)-2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol; (−)-Venlafaxine;
Application:
S-Venlafaxine is an optically active version of venlafaxine
CAS Number:
93413-44-6
Molecular Weight:
277.40
Molecular Formula:
C17H27NO2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

S-Venlafaxine is an optically active version of Venlafaxine (sc-201102). Venlafaxine is a derivative of phenylethylamine which is reported to facilitate neurotransmission within the central nervous system via blocking the presynaptic reuptake of neuroamines such as serotonin (5-hydroxytryptamine; 5-HT) and noradrenaline (norepinephrine). Venlafaxine is also reported to be a weak inhibitor of dopamine reuptake. In vitro studies indicate that Venlafaxine does not demonstrate significant activity for muscarinic, histaminergic or α-1 adrenergic receptors. The metabolism of venlafaxine is reported to occur by cytochrome P450 (CYP) enzyme CYP2D6 yielding O-desmethylvenlafaxine. A lesser metabolite, N-desmethylvenlafaxine is produced by CYP3A4.


S-Venlafaxine (CAS 93413-44-6) References

  1. Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions: a case report.  |  Eap, CB., et al. 2000. Pharmacopsychiatry. 33: 112-5. PMID: 10855463
  2. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.  |  Bymaster, FP., et al. 2001. Neuropsychopharmacology. 25: 871-80. PMID: 11750180
  3. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.  |  Stahl, SM., et al. 2005. CNS Spectr. 10: 732-47. PMID: 16142213
  4. The disposition of venlafaxine enantiomers in dogs, rats, and humans receiving venlafaxine.  |  Wang, CP., et al. 1992. Chirality. 4: 84-90. PMID: 1616828
  5. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.  |  Blier, P., et al. 2007. Int J Neuropsychopharmacol. 10: 41-50. PMID: 16690005
  6. CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine.  |  Shams, ME., et al. 2006. J Clin Pharm Ther. 31: 493-502. PMID: 16958828
  7. In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5-hydroxytryptamine(1A) receptors.  |  Berrocoso, E. and Mico, JA. 2007. J Pharmacol Exp Ther. 322: 101-7. PMID: 17431134
  8. Venlafaxine. A review of its pharmacology and therapeutic potential in depression.  |  Holliday, SM. and Benfield, P. 1995. Drugs. 49: 280-94. PMID: 7729333
  9. Venlafaxine: a new antidepressant drug.  |  Holdcroft, C. 1994. Nurse Pract. 19: 21. PMID: 7816367
  10. Venlafaxine oxidation in vitro is catalysed by CYP2D6.  |  Otton, SV., et al. 1996. Br J Clin Pharmacol. 41: 149-56. PMID: 8838442

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

S-Venlafaxine, 5 mg

sc-208330
5 mg
$430.00